Amphastar Pharmaceuticals, Inc. (AMPH) — 10-Q Filings
All 10-Q filings from Amphastar Pharmaceuticals, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Amphastar's Q3 Net Income Plummets 57% Amid Soaring Expenses
— Nov 6, 2025 Risk: high
Amphastar Pharmaceuticals, Inc. reported a significant decline in net income for the three and nine months ended September 30, 2025, despite a slight increase i -
Amphastar Boosts Share Buybacks, Reports Steady Product Revenue
— Aug 7, 2025 Risk: low
Amphastar Pharmaceuticals, Inc. filed its 10-Q on August 7, 2025, for the quarter ended June 30, 2025. The company reported significant activity in its share re -
Amphastar Pharmaceuticals Files 10-Q for Q1 2025
— May 8, 2025 Risk: low
Amphastar Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information including common stock, retained e -
Amphastar Pharmaceuticals Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
Amphastar Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial performance and activities, inclu -
Amphastar Pharmaceuticals Q2 2024 10-Q Filing
— Aug 9, 2024 Risk: medium
Amphastar Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the sec -
Amphastar Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024
— May 10, 2024 Risk: low
Amphastar Pharmaceuticals, Inc. (AMPH) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Amphastar Pharmaceuticals, Inc. filed a 10-Q report for the
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX